Important Statement
This report is prepared by Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. (hereinafter referred to as "Shenwan Hongyuan") based on the "Administrative Measures for the Issuance and Trading of Corporate Bonds," the "Trust Management Agreement for the Public Issuance of Convertible Bonds by Tibet Cheezheng Tibetan Medicine Co., Ltd." (hereinafter referred to as "Trust Management Agreement"), the "Prospectus for the Public Issuance of Convertible Bonds by Tibet Cheezheng Tibetan Medicine Co., Ltd." (hereinafter referred to as "Prospectus"), the "2025 Annual Report of Tibet Cheezheng Tibetan Medicine Co., Ltd." and other relevant public information disclosure documents, as well as professional opinions issued by third-party intermediaries. Shenwan Hongyuan does not independently verify the contents and information quoted from the above documents and does not guarantee or assume any responsibility for the authenticity, accuracy, and completeness of such quoted contents and information. This report does not constitute a recommendation for investors to take or refrain from any action; investors should make independent judgments on related matters and should not rely on any content in this report as a commitment or statement made by Shenwan Hongyuan. Under no circumstances shall Shenwan Hongyuan be liable for any actions or inactions taken by investors based on this report.
Table of Contents
- Overview of the Convertible Bonds
- Approval Documents and Approval Scale
- Main Terms of the Convertible Bonds
- Performance of the Bond Trustee
- Annual Operating and Financial Conditions of the Issuer
- Use of Funds Raised by the Issuer
- Guarantor Information for the Bonds
- Bondholders' Meeting
- Interest Payment Status of the Bonds
- Tracking Rating of the Bonds
- Other Matters Affecting Bondholders' Rights
Chapter 1: Overview of the Convertible Bonds
1. Approval Documents and Approval Scale
Tibet Cheezheng Tibetan Medicine Co., Ltd. (hereinafter referred to as "Cheezheng Tibetan Medicine," "the Company," or "the Issuer") held the 18th meeting of the fourth board of directors and the second extraordinary general meeting of shareholders on January 16, 2020, and February 11, 2020, respectively, to review and approve the issuance of the bonds and related plans. The China Securities Regulatory Commission (hereinafter referred to as "CSRC") approved the public issuance of convertible bonds by Tibet Cheezheng Tibetan Medicine Co., Ltd. (Approval No. [2020] 1766) for a total of 800 million RMB, with each bond having a face value of 100 RMB. The bonds were issued at face value, with a total issuance amount of 800 million RMB and a term of six years. The Shenzhen Stock Exchange (hereinafter referred to as "SZSE") approved the listing of the 800 million RMB convertible bonds, which began trading on October 27, 2020, under the name "Cheezheng Convertible Bonds" and the code "128133."